imidazole has been researched along with Hypersensitivity, Type III in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajiwara, M | 1 |
| Ueno, T | 1 |
| Fukuda, N | 1 |
| Matsuda, H | 1 |
| Shimokawa, T | 1 |
| Kitai, M | 1 |
| Tsunemi, A | 1 |
| Fuke, Y | 1 |
| Fujita, T | 1 |
| Matsumoto, K | 1 |
| Matsumoto, Y | 1 |
| Ra, C | 1 |
| Soma, M | 1 |
1 other study available for imidazole and Hypersensitivity, Type III
| Article | Year |
|---|---|
Development of pyrrole-imidazole polyamide targeting fc receptor common gamma chain for the treatment of immune-complex related renal disease.
Topics: Animals; Cell Line; Cells, Cultured; Gene Expression Regulation; Imidazoles; Immune Complex Diseases | 2012 |